Global Plant-Based Vaccines Market
Pharmaceuticals

Plant-Based Vaccines Market to Grow at a CAGR of 10.8% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Plant-Based Vaccines Market?

The market for plant-based vaccines has shown substantial growth recently. It is projected to expand from $1.66 billion in 2024 to $1.81 billion in 2025, driven by a compound annual growth rate (CAGR) of 8.9%. This historical expansion can be attributed to several factors, including challenges in traditional vaccine production, the necessity for cost-effective vaccine manufacturing, the emergence of plant molecular farming, its reduced allergenic potential, and the application of synthetic biology.

The plant-based vaccines market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $2.72 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.8%. This expansion over the forecast period is driven by factors such as pandemic preparedness, global health security enhancements, the widening scope of vaccine applications, and increased adoption within the pharmaceutical industry. Prominent trends for this period encompass technological breakthroughs in plant biotechnology, a strong emphasis on environmental sustainability, and the integration of artificial intelligence and ML.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

Which Drivers Are Supporting Growth Of The Plant-Based Vaccines Market?

The increasing widespread occurrence of infectious diseases is projected to drive the expansion of the plant-based vaccine market in the future. These diseases originate from microorganisms such as bacteria, viruses, fungi, or parasites. Plant-based vaccines are utilized in both conventional and modern medical practices for various ailments, including infectious conditions, offering the potential to develop safe, efficacious, stable, and cost-effective preventive measures, immunizations, and treatments. This is exemplified by the situation in October 2022, when, as per the Global Tuberculosis Report issued by the World Health Organization, a Switzerland-based global health agency, the worldwide occurrence of tuberculosis (TB) was estimated at 10.6 million cases, reflecting a rate of 134 cases per 100,000 population. Within this total, the Southeast Asia region accounted for 45% of the reported TB cases, with Africa following at 23%. Such a significant burden of infectious diseases clearly propels the demand and growth of the plant-based vaccine market.

How Is The Plant-Based Vaccines Market Classified Into Different Segments?

The plant-based vaccines market covered in this report is segmented –

1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

2) By Source: Tobacco Plant, Maize, Potato, Other Sources

3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

Subsegments:

1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines

2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines

3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines

4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines

How Are Emerging Market Trends Shaping The Plant-Based Vaccines Industry Landscape?

A notable trend increasing in prevalence within the plant-based vaccine market is product innovation. Major companies operating in the plant-based vaccine market are dedicating efforts to creating innovative products to uphold their standing. As an illustration, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical and biotechnology company, announced that Health Canada had approved COVIFENZ, their COVID-19 vaccine. COVIFENZ represents the initial plant-based virus-like particles (VLP), recombinant, adjuvanted vaccine accessible for COVID-19 disease. COVIFENZ leverages the COVID-19-like particle (CoVLP) technology. The vaccine is constituted by recombinant spike (S) glycoproteins generated as virus-like particles (VLPs).

Which Industry Leaders Are Driving Innovation Across The Plant-Based Vaccines Market?

Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

Which Regional Markets Are Contributing Most To The Plant-Based Vaccines Industry Expansion?

North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Plant-Based Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp

Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2025, By The Business Research Company

Motor Vehicle And Parts Dealers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/motor-vehicle-and-parts-dealers-global-market-report

Automobiles And Heavy Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automobiles-and-heavy-equipment-global-market-report

Electric Motor And Generator Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model